On November 6, 2018 Emergent BioSolutions Inc. (NYSE: EBS) reported that a member of the company’s senior management team will participate in the following investor conferences during the fourth quarter and early portion of the first quarter of 2019 (Press release, Emergent BioSolutions, NOV 6, 2018, View Source;p=RssLanding&cat=news&id=2375511 [SID1234530772]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
JP Morgan – 2018 CEO Conference Call Series
Virtual/Conference Call (information to be provided by JP Morgan)
November 13, 2018
Three Part Advisors – 2018 Southwest IDEAS Investor Conference
Dallas, TX
November 14-15, 2018
Piper Jaffray – 30th Annual Healthcare Conference
New York, NY
November 27-29, 2018
Mizuho – Global Mizuho Investor Conference
New York, NY
December 3, 2018
BMO Capital Markets – 2018 Prescriptions for Success Healthcare Conference
New York, NY
December 12, 2018
JP Morgan – 37th Annual Healthcare Conference
San Francisco, CA
January 7-10, 2019
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under "Investors" as the information becomes available.
For these conferences, the company will be webcasting its presentation, which may include a discussion of the company’s recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.